| Issuer | % of Class | Filed |
|---|---|---|
|
Ernexa Therapeutics Inc.
13G/A
Amendment 3
ERNA · 114082308
|
4.1% |
8/18/2025
Event 7/28/2025
|
|
Ernexa Therapeutics Inc.
13G/A
Amendment 2
ERNA · 114082209
|
5.2% |
5/14/2025
Event 3/31/2025
|
|
Eterna Therapeutics Inc.
13G/A
Amendment 1
ERNA · 114082209
|
5.2% |
2/12/2025
Event 10/29/2024
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.